William R. Hutson

William R. Hutson, MD, AGAF, FAASLD

Languages spoken: English

Academic Information

Departments Primary - Internal Medicine

Divisions: Gastroenterology

Board Certification

  • American Board of Internal Medicine (Internal Medicine)
  • American Board of Internal Medicine (Sub: Gastroenterology)
  • American Board of Internal Medicine (Sub: Transplant Hepatology)
  • Federal Licensing Examination

Research Interests

  • Liver Transplantation
  • Hepatitis C
  • Cholangiocarcinoma
  • Liver Diseases
  • Non-alcoholic Fatty Liver Disease

William Hutson, MD, is professor of medicine, director of hepatology, and medical director of liver transplantation in the Division of Gastroenterology and Hepatology at the University of Utah School of Medicine. He is also an investigator and clinician with the Gastrointestinal Cancer Program at Huntsman Cancer Institute (HCI).

His clinical specialty is treatment of liver disease and liver transplants. Hutson's research interests include hepatitis C, especially as it affects liver transplant patients, and insulin resistance associated with hepatitis C. In addition, he studies the treatment of cholangiocarcinoma with liver transplantation, as well the treatment of fatty liver disease and hepatocellular carcinoma. His research also includes establishment of a hepatic research registry.

Hutson received his medical degree from West Virginia University in Morgantown in 1982, and he completed internship and residency at West Virginia University/Charleston Area Medical Center in Charleston. In addition, he completed a fellowship in gastroenterology at University Health Center of Pittsburgh in Pennsylvania.

Education History

Fellowship University Health Center of Pittsburgh
 Fellow
West Virginia University Hospital/Charleston Area Medical Center
 Resident
Internship West Virginia University Hospital/Charleston Area Medical Center
 Intern
West Virginia University School of Medicine
 MD
Undergraduate West Virginia University
 BA

Selected Publications

Journal Article

  1. Pakhchanian H, Raiker R, Karde S, Bilal M, Alam K, Khan A, Hutson W, Thakkar S, Singh S (2021). Impact of COVID-19 on interest in hepato-pancreato-biliary diseases. Environ Sci Pollut Res Int, 29(4), 5771-5776. (Read full article)
  2. Hadi YB, Thakkar S, Shah-Khan SM, Hutson W, Sarwari A, Singh S (2021). COVID-19 Vaccination Is Safe and Effective in Patients With Inflammatory Bowel Disease: Analysis of a Large Multi-institutional Research Network in the United States. Gastroenterology, 161(4), 1336-1339.e3. (Read full article)
  3. Cimeno A, Sultan S, Alvarez-Casas J, Hanish SI, Bruno DA, Hutson WR, Stein DM, Scalea TM, Barth RN, LaMattina JC (2021). Transplant Hepatectomy With Portacaval Shunt and MARS Therapy for Perioperative Catastrophe: A Series of Four Liver Transplant Cases. Transplant Direct, 7(3), e674. (Read full article)
  4. Chaudhary F, Albeiruti R, Alqahtani F, Alhajji M, Lerfald N, Hutson W (2020). Temporal Trends and Predictors of Pancreatitis Patients Who Leave Against Medical Advice: A Nationwide Analysis. Gastroenterology Res, 13(2), 58-65. (Read full article)
  5. Mindikoglu AL, Opekun AR, Putluri N, Devaraj S, Sheikh-Hamad D, Vierling JM, Goss JA, Rana A, Sood GK, Jalal PK, Inker LA, Mohney RP, Tighiouart H, Christenson RH, Dowling TC, Weir MR, Seliger SL, Hutson WR, Howell CD, Raufman JP, Magder LS, Coarfa C (2017). Unique metabolomic signature associated with hepatorenal dysfunction and mortality in cirrhosis. Transl Res, 195, 25-47. (Read full article)
  6. Hanish SI, Stein DM, Scalea JR, Essien EO, Thurman P, Hutson WR, Bartlett ST, Barth RN, Scalea TM (2017). Molecular Adsorbent Recirculating System Effectively Replaces Hepatic Function in Severe Acute Liver Failure. Ann Surg, 266(4), 677-684. (Read full article)
  7. Posner AD, Sultan ST, Zaghloul NA, Twaddell WS, Bruno DA, Hanish SI, Hutson WR, Hebert L, Barth RN, LaMattina JC (2017). Resolution of donor non-alcoholic fatty liver disease following liver transplantation. Clin Transplant, 31(9). (Read full article)
  8. Ahmad SB, Miller M, Hanish S, Bartlett ST, Hutson W, Barth RN, LaMattina JC (2016). Sequential kidney-liver transplantation from the same living donor for lecithin cholesterol acyl transferase deficiency. Clin Transplant, 30(10), 1370-1374. (Read full article)
  9. Mindikoglu AL, Dowling TC, Magder LS, Christenson RH, Weir MR, Seliger SL, Hutson WR, Howell CD (2015). Estimation of Glomerular Filtration Rate in Patients With Cirrhosis by Using New and Conventional Filtration Markers and Dimethylarginines. Clin Gastroenterol Hepatol, 14(4), 624-632.e2. (Read full article)
  10. Mindikoglu AL, Dowling TC, Schaub DJ, Hutson WR, Potosky DR, Christenson RH, Barth RN, LaMattina JC, Hanish SI, Weir MR, Raufman JP (2015). Pharmacokinetics and Tolerability of Intravenous Sildenafil in Two Subjects with Child-Turcotte-Pugh Class C Cirrhosis and Renal Dysfunction. Dig Dis Sci, 60(11), 3491-4. (Read full article)
  11. LaMattina JC, Kelly PJ, Hanish SI, Ottmann SE, Powell JM, Hutson WR, Sivaraman V, Udekwu O, Barth RN (2015). Intraoperative Continuous Veno-Venous Hemofiltration Facilitates Surgery in Liver Transplant Patients With Acute Renal Failure. Transplant Proc, 47(6), 1901-4. (Read full article)
  12. LaMattina JC, Jason MP, Hanish SI, Ottmann SE, Klassen DK, Potosky D, Hutson WR, Barth RN (2013). Safety of belatacept bridging immunosuppression in hepatitis C-positive liver transplant recipients with renal dysfunction. Transplantation, 97(2), 133-7. (Read full article)
  13. Mindikoglu AL, Dowling TC, Wong-You-Cheong JJ, Christenson RH, Magder LS, Hutson WR, Seliger SL, Weir MR (2014). A pilot study to evaluate renal hemodynamics in cirrhosis by simultaneous glomerular filtration rate, renal plasma flow, renal resistive indices and biomarkers measurements. Am J Nephrol, 39(6), 543-52. (Read full article)
  14. Schwartz JJ, Pappas L, Thiesset HF, Vargas G, Sorensen JB, Kim RD, Hutson WR, Boucher K, Box T (2012). Liver transplantation in septuagenarians receiving model for end-stage liver disease exception points for hepatocellular carcinoma: the national experience. Liver Transpl, 18(4), 423-33. (Read full article)
  15. Gorman DR, Hutson WR (2011). Successful endoscopic removal of metal vascular coils from the biliary tree. Dig Liver Dis, 43(12), e27. (Read full article)
  16. Schwartz JJ, Thiesset HF, Clayton F, Adler DG, Hutson WR, Carlisle JG (2011). Using the modern Silverhawk atherectomy catheter to characterize biliary structures that appear malignant: review of initial experience. HPB (Oxford), 13(11), 823-9. (Read full article)
  17. Schwartz JJ, Rohrwassen A, Hilas E, Hatch J, Sorensen JB, Gayowski TJ, Hutson WR, Lalouel J (2009). A real-time telemetric method for continuous measurement of portal pressures. J Surg Res, 10(1), 1-4.

Review

  1. Farshidpour M, Hutson W (2022). Immune Checkpoint Inhibitors Induced Hepatotoxicity; Gastroenterologists' Perspectives. [Review]. Middle East J Dig Dis, 14(2), 244-253. (Read full article)
  2. Brown SA, Axenfeld E, Stonesifer EG, Hutson W, Hanish S, Raufman JP, Urrunaga NH (2018). Current and prospective therapies for acute liver failure. [Review]. Dis Mon, 64(12), 493-522. (Read full article)
  3. Harrison JD, Selzman CH, Thiesset HF, Box T, Hutson WR, Lu JK, Campsen J, Sorensen JB, Kim RD (2013). Minimally invasive aortic valve replacement with orthotopic liver transplantation: report of a case. [Review]. Surg Today, 44(3), 546-9. (Read full article)
  4. Schwartz JJ, Hutson WR, Gayowski TJ, Sorensen JB (2009). Liver transplantation for cholangiocarcinoma. [Review]. Transplantation, 88(3), 295-8. (Read full article)

Book Chapter

  1. Hutson W (2011). Which patients with cholangiocarcinoma are candidates for surgical resection? Is liver transplant an option for patients with cholangiocarcinoma? In Douglas G. Adler (Ed.), Curbside Consultation (p. 137). Thorofare: Slack Incorporated.

Case Report

  1. Deneau M, Adler DG, Schwartz JJ, Hutson W, Sorensen J, Book L, Lowichik A, Guthery S (2011). Cholangiocarcinoma in a 17-year-old boy with primary sclerosing cholangitis and inflammatory bowel disease. J Pediatr Gastroenterol Nutr, 52(5), 617-620.
  2. Schwartz JJ, Hatch JM, Book Z, Lonardo N, Hutson WR, Sorensen JB (2009). Use of argatroban during multi-organ procurement: pharmacokinetics and sequelae in recipient of transplanted liver. Clin Transplant, 23(5), 705-9. (Read full article)
  3. Lynch CR, Folkers ME, Hutson WR (2006). Fulminant hepatic failure associated with the use of black cohosh: a case report. Liver Transpl, 12(6), 989-92. (Read full article)

Letter

  1. Alkhatib AA, Maldonado AQ, Abdel Jalil A, Hutson W (2013). Physicians' attitude toward organ donation and transplantation in the USA. [Letter to the editor]. Clin Transplant, 28(2), 149-51. (Read full article)